Electrographic flow mapping of persistent atrial fibrillation: intra- and inter-procedure reproducibility in the absence of 'ground truth'.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
02 Nov 2023
Historique:
received: 15 06 2023
accepted: 09 10 2023
medline: 15 11 2023
pubmed: 13 11 2023
entrez: 13 11 2023
Statut: ppublish

Résumé

Validating mapping systems that identify atrial fibrillation (AF) sources (focal/rotational activity) is confounded by the absence of ground truth. A key concern of prior mapping technologies is spatiotemporal instability, manifesting as poor map reproducibility. Electrographic flow (EGF) employs a novel algorithm that visualizes atrial electrical wavefront propagation to identify putative AF sources. We analysed both intra- (3 min) and inter- (>3 months) procedure EGF map reproducibility. In 23 persistent AF patients, after pulmonary vein isolation (PVI), EGF maps were generated from 3 serial 1 min recordings using a 64-electrode basket mapping catheter (triplets) at right and left atrial locations. Source prevalence from map triplets was compared between recordings. Per protocol, 12 patients returned for 3-month remapping (1 non-inducible): index procedure post-PVI EGF maps were compared with initial EGF remapping at 3-month redo. Intra-procedure reproducibility: analysing 224 map triplets (111 right atrium, 113 left atrium) revealed a high degree of map consistency with minimal min-to-min shifts: 97 triplets (43%), exact match of leading sources on all 3 maps; 95 triplets (42%), leading source within 1 electrode space on 2 of 3 maps; and 32 triplets (14%), chaotic leading source pattern. Average deviation in source prevalence over 60 s was low (6.4%). Inter-procedure reproducibility: spatiotemporal stability of EGF mapping >3 months was seen in 16 of 18 (89%) sources mapped in 12 patients with (re)inducible AF. Electrographic flow mapping generates reproducible intra- and inter-procedural maps, providing rationale for randomized clinical trials targeting these putative AF sources.

Identifiants

pubmed: 37956309
pii: 7416771
doi: 10.1093/europace/euad308
pmc: PMC10642765
pii:
doi:

Substances chimiques

Epidermal Growth Factor 62229-50-9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ablacon

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Int J Cardiol. 2019 Jul 1;286:56-60
pubmed: 30773268
J Am Heart Assoc. 2017 Aug 22;6(8):
pubmed: 28862969
Pacing Clin Electrophysiol. 2019 May;42(5):499-507
pubmed: 30882924
Heart Rhythm. 2009 Jan;6(1):33-40
pubmed: 19121797
Eur Heart J. 2015 Sep 14;36(35):2390-401
pubmed: 26059724
J Interv Card Electrophysiol. 2023 Jun;66(4):1015-1028
pubmed: 35969338
J Am Coll Cardiol. 2014 May 6;63(17):1761-8
pubmed: 24632280
Europace. 2023 Mar 30;25(3):783-792
pubmed: 36734272
PLoS Comput Biol. 2018 Mar 5;14(3):e1006017
pubmed: 29505583
J Cardiovasc Electrophysiol. 2021 Aug;32(8):2148-2158
pubmed: 34041824
J Cardiovasc Electrophysiol. 2021 Sep;32(9):2393-2403
pubmed: 34260134
JACC Clin Electrophysiol. 2018 Dec;4(12):1501-1515
pubmed: 30573112
Heart Rhythm. 2020 May;17(5 Pt A):683-691
pubmed: 31991116
Heart Rhythm O2. 2023 Apr 23;4(6):391-400
pubmed: 37361617
Clin Res Cardiol. 2018 Nov;107(11):1021-1032
pubmed: 29744616
J Cardiovasc Electrophysiol. 2013 Mar;24(3):328-35
pubmed: 23210508
Europace. 2023 Feb 8;25(1):74-82
pubmed: 36056882
N Engl J Med. 2015 May 7;372(19):1812-22
pubmed: 25946280
Circulation. 2006 Feb 7;113(5):616-25
pubmed: 16461833
J Am Coll Cardiol. 2012 Aug 14;60(7):628-36
pubmed: 22818076
Circ Arrhythm Electrophysiol. 2015 Apr;8(2):308-17
pubmed: 25744570
JACC Clin Electrophysiol. 2018 Jan;4(1):124-134
pubmed: 29387810
Heart Rhythm. 2017 Oct;14(10):e275-e444
pubmed: 28506916
Cardiovasc Res. 2016 Apr 1;109(4):480-92
pubmed: 26786157
Eur Cardiol. 2021 May 17;16:e21
pubmed: 34093742
Front Cardiovasc Med. 2023 Sep 01;10:1223481
pubmed: 37719974
Circulation. 2014 Aug 12;130(7):530-8
pubmed: 25028391
Circ Arrhythm Electrophysiol. 2019 Jul;12(7):e007233
pubmed: 31242746
JACC Clin Electrophysiol. 2021 Jul;7(7):923-932
pubmed: 33812838
HeartRhythm Case Rep. 2021 Jun 09;7(9):599-604
pubmed: 34552851
Pacing Clin Electrophysiol. 2023 Jul;46(7):771-781
pubmed: 37260105
Circ Arrhythm Electrophysiol. 2021 Jun;14(6):e009602
pubmed: 33999670
Circ Arrhythm Electrophysiol. 2020 Jan;13(1):e007825
pubmed: 31944826
J Cardiovasc Electrophysiol. 2018 Nov;29(11):1480-1488
pubmed: 30230079
Circulation. 2015 Dec 1;132(22):2108-17
pubmed: 26499963

Auteurs

Vivek Y Reddy (VY)

Helmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, PO Box 1030, NewYork, NY 10029, USA.
Department of Cardiology, Homolka Hospital, Roentgenova 37/2, Prague 5, Czech Republic.

Melissa H Kong (MH)

Ablacon Inc.,Wheat Ridge, CO, USA.

Jan Petru (J)

Department of Cardiology, Homolka Hospital, Roentgenova 37/2, Prague 5, Czech Republic.

Abhishek Maan (A)

Helmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, PO Box 1030, NewYork, NY 10029, USA.

Moritoshi Funasako (M)

Department of Cardiology, Homolka Hospital, Roentgenova 37/2, Prague 5, Czech Republic.

Kentaro Minami (K)

Department of Cardiology, Homolka Hospital, Roentgenova 37/2, Prague 5, Czech Republic.

Peter Ruppersberg (P)

Ablacon Inc.,Wheat Ridge, CO, USA.

Srinivas Dukkipati (S)

Helmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, PO Box 1030, NewYork, NY 10029, USA.

Petr Neuzil (P)

Department of Cardiology, Homolka Hospital, Roentgenova 37/2, Prague 5, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH